A composition, comprising: a physiologically-acceptable polydimethylsiloxane having a surface; and one or more normal C.sub.6-C.sub.20NR.sub.1R.sub.2 saturated amine, salt thereof, or combination thereof, in contact with the polydimethylsiloxane, the surface, or both, wherein R.sub.1 and R.sub.2 may be same or different and independently selected from H, —CH.sub.3, —CH.sub.2CH.sub.3, —CH.sub.2CH.sub.2CH.sub.3, or combination thereof.

This invention relates to compositions and medical devices comprising anti-microbial active particles, for inhibiting microbial growth. This invention further provides methods of making such compositions and medical devices.

This invention relates to compositions and medical devices comprising anti-microbial active particles, for inhibiting microbial growth. This invention further provides methods of making such compositions and medical devices.

This invention relates to compositions and medical devices comprising anti-microbial active particles, for inhibiting microbial growth. This invention further provides methods of making such compositions and medical devices.

The present disclosure describes a treated cellulosic material comprising: a cellulosic material having a porous structure defining a plurality of pores, at least a portion of the pores containing a treating agent comprising: a polymer comprising an olefin-carboxylic acid copolymer; and a modifying agent comprising a hydrophobic amine.

Compositions, devices, and methods are disclosed for treating or preventing fungal infection in an animal are provided. The methods involve exposing the animal to one or more volatile organic compounds (VOCs) in a quantity sufficient to inhibit or reduce fungal growth in the animal. Also disclosed is an automated aerosolization unit (AAU) for delivering compositions, such as the disclosed VOCs, to areas, such as habitats, to treat or prevent fungal infections in animals.

Compositions, devices, and methods are disclosed for treating or preventing fungal infection in an animal are provided. The methods involve exposing the animal to one or more volatile organic compounds (VOCs) in a quantity sufficient to inhibit or reduce fungal growth in the animal. Also disclosed is an automated aerosolization unit (AAU) for delivering compositions, such as the disclosed VOCs, to areas, such as habitats, to treat or prevent fungal infections in animals.

The present disclosure provides compositions and methods for treating volatile fatty acids and bacteria capable of producing volatile fatty acids. The compositions can convert acid-producing bacteria environments to nitrate-reducing bacteria environments. The compositions and methods can lower the amount of acid-producing bacteria present in the environment and thereby reduce the amount of volatile fatty acids present in the environment. The control agent may also inhibit the growth of acid-producing bacteria and volatile fatty acid concentrations. The compositions and methods can be used with any aqueous industrial system.

A composition. The composition includes a compound of Formula (I) HOCH.sub.2—(═CHOH═).sub.n—CH2NR.sup.1R.sup.2 (I) wherein R.sup.1 and R.sup.2 are independently selected from the group consisting of a hydrogen atom, an alkyl group, C(O)R.sup.3, and SO.sub.2R.sup.4, wherein at least one of R.sup.1 and R.sup.2 is C(O)R.sup.3 or SO.sub.2R.sup.4, R.sup.3 and R.sup.4 are selected from the group consisting of an alkyl group having seven carbon atoms, an alkyl group having eight carbon atoms, and an alkyl group having nine carbon atoms, and n is an integer from about 2 to about wherein a concentration of the compound of Formula (I) is more than its critical micelle concentration; and an antimicrobial agent selected from the group consisting of a biguanide antimicrobial agent and a polymeric, cationic, non-micelle forming antimicrobial material; wherein a concentration of the antimicrobial agent is no more than 5 wt %.

A composition. The composition includes a compound of Formula (I) HOCH.sub.2—(═CHOH═).sub.n—CH2NR.sup.1R.sup.2 (I) wherein R.sup.1 and R.sup.2 are independently selected from the group consisting of a hydrogen atom, an alkyl group, C(O)R.sup.3, and SO.sub.2R.sup.4, wherein at least one of R.sup.1 and R.sup.2 is C(O)R.sup.3 or SO.sub.2R.sup.4, R.sup.3 and R.sup.4 are selected from the group consisting of an alkyl group having seven carbon atoms, an alkyl group having eight carbon atoms, and an alkyl group having nine carbon atoms, and n is an integer from about 2 to about wherein a concentration of the compound of Formula (I) is more than its critical micelle concentration; and an antimicrobial agent selected from the group consisting of a biguanide antimicrobial agent and a polymeric, cationic, non-micelle forming antimicrobial material; wherein a concentration of the antimicrobial agent is no more than 5 wt %.